Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,600.00
-1,380.00 (-12.57%)
At close: Dec 5, 2025

Pharos iBio Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
124,28198,001191,588---
Upgrade
Market Cap Growth
2.03%-48.85%----
Upgrade
Enterprise Value
115,64380,945164,210---
Upgrade
Last Close Price
9600.007570.0014830.00---
Upgrade
PB Ratio
10.905.276.76---
Upgrade
P/TBV Ratio
11.295.396.79---
Upgrade
Debt / Equity Ratio
0.020.010.010.02-0.04-0.68
Upgrade
Asset Turnover
---0.010.000.02
Upgrade
Quick Ratio
10.9716.2521.1516.060.560.86
Upgrade
Current Ratio
11.3216.7021.5716.530.570.88
Upgrade
Return on Equity (ROE)
-61.86%-44.97%-38.50%-1825.61%--
Upgrade
Return on Assets (ROA)
-42.99%-31.94%-26.12%-28.73%-23.78%-32.64%
Upgrade
Return on Capital (ROIC)
-44.64%-33.24%-27.09%-469.65%--
Upgrade
Return on Capital Employed (ROCE)
-99.30%-67.50%-35.50%-59.80%55.20%1120.40%
Upgrade
Earnings Yield
-7.90%-10.78%-4.62%---
Upgrade
FCF Yield
-6.93%-10.21%-4.31%---
Upgrade
Buyback Yield / Dilution
-0.11%-6.79%-36.26%-53.03%-2.65%-1.86%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.